Does Verteporfin For Injection Interact with Calcium Channel Blockers?
CDI records a moderate classification for Verteporfin For Injection and Calcium Channel Blockers. The stored summary is: Could enhance the rate of VISUDYNE uptake by the vascular endothelium, potentially increasing photodynamic effects. The mechanism involves enhanced vascular endothelial uptake. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Verteporfin For Injection Class
- Photoenhancer
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Enhanced vascular endothelial uptake
What To Tell Your Doctor or Pharmacist
If you are taking Verteporfin For Injection and your doctor is considering prescribing Calcium Channel Blockers (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider